Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice - Wikidata - wikimedia - TriplyDB

Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice

Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice

http://www.wikidata.org/entity/Q33933963

about

An Inventory of Methods for the Assessment of Additive Increased Addictiveness of Tobacco Products On-Line Chemical Composition Analysis of Refillable Electronic Cigarette Aerosol-Measurement of Nicotine and Nicotyrine.Effects of Menthol on Nicotine Pharmacokinetic, Pharmacology and Dependence in Mice.Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers In vivo modulation of the behavioral effects of nicotine by the coumarins xanthotoxin, bergapten, and umbelliferone In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.Nicotine prevents and reverses paclitaxel-induced mechanical allodynia in a mouse model of CIPN.

P2860

Q28075342-C36B5258-D2A4-439F-856A-C7E3AD2F6E80 Q34455797-69FF83B2-20EB-4F34-BF50-750416617962 Q35768916-03C52C79-3715-4452-9638-6574931E09D4 Q36421698-D41FC4BF-AF01-4537-B49A-7F54BBE5EF52 Q36918424-1B750275-FE99-4F2D-B712-F2601FA605CC Q45054305-68D6C932-C87E-4CF5-9391-8587AED7CBA6 Q45070329-562DBAB3-9F13-4B0D-88A2-AA27712DBC0B

P2860

Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice

http://www.wikidata.org/entity/Q33933963

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice

@ast

Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice

@en

type

label

Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice

@ast

Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice

@en

prefLabel

Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice

@ast

Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice

@en

P1433

Q33933963-9D1EF9BB-E16E-4FC7-9F9B-C39682FE0805

P1476

Q33933963-7E45E71B-4BFB-4A3D-A647-4C2699B351E1

P2093

Q33933963-2BFF20FD-A7AB-4A58-8522-36E99E2E174C

Q33933963-BB4398B4-19A6-449F-99D3-FDBDC61F9DC6

Q33933963-CAB9A0CC-E0A8-4F44-9A08-AC70BF8F142A

Q33933963-CF394100-CF3B-4D79-A991-7E7F56B17E78

P2860

Q33933963-12E54FC3-6526-4014-AD26-6FF51445C03B

Q33933963-1BB591CA-3D70-4E8C-8A75-DBBBF6C477DD

Q33933963-221A5C1F-33BD-458F-8F31-CB63D76CB600

Q33933963-34FDB508-C413-4976-8DE1-37754DA00460

Q33933963-438B1E42-84A7-4014-8B44-742B87E4391E

Q33933963-597E9FCF-614F-4761-864D-8A387B11CDAF

Q33933963-680D8A28-16FA-483C-AE20-BD73C93C42ED

Q33933963-69E0CB46-F4ED-4DF1-A8EA-F7C27278577A

Q33933963-6D1C1963-6304-478F-A839-58331E0B7DAE

Q33933963-6D37D879-2954-4322-B2A7-4834E09570DF

P304

Q33933963-737FA8C5-4554-412A-9B03-8F10C1FBF05D

P31

Q33933963-CDBEDACF-3A15-4DA4-A748-D280AC0A1046

P356

Q33933963-247FB1BA-9609-4F7B-BD9A-B1E3A6FD3E7E

P478

Q33933963-8EDA59DA-599F-4722-8242-D3F09EC82EDB

P50

Q33933963-F5D4A90A-0113-4543-BAE7-3E43578EE51B

P577

Q33933963-8C26B962-76CB-48EF-8BFC-0C2B21688B7A

P698

Q33933963-F75A97A4-4C97-44EA-9479-12D849EB6F6E

P932

Q33933963-D9E54879-33BB-4FF3-89B7-21A2A6382B4A

P356

J.NEUROPHARM.2014.05.006

P1433

Neuropharmacology

P1476

Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice

@en

P2093

Andy Z X Zhu

http://www.w3.org/2001/XMLSchema#string

Deniz Bagdas

http://www.w3.org/2001/XMLSchema#string

M Imad Damaj

http://www.w3.org/2001/XMLSchema#string

Pretal P Muldoon

http://www.w3.org/2001/XMLSchema#string

P2860

Nicotine chemistry, metabolism, kinetics and biomarkers

Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status

Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.

Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse model

Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers

Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes

Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs.

Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse.

Pharmacokinetic and pharmacodynamics studies of nicotine after oral administration in mice: effects of methoxsalen, a CYP2A5/6 inhibitor.

Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans.

P304

67-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROPHARM.2014.05.006

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Rachel F Tyndale

P577

2014-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24859605

http://www.w3.org/2001/XMLSchema#string

P932

4106981

http://www.w3.org/2001/XMLSchema#string